Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model

The current study evaluated antidiabetic and antihyperlipidemic activities of aqueous extract of Sigesbeckia orientalis L. (St. Paul’s Wort) (AESO) in an alloxan-induced diabetic rat model. Following OECD guidelines safe doses of AESO were assessed in rats for the main study. Serum/bood glucose, α-a...

Full description

Bibliographic Details
Main Authors: Muhammad Asif, Mohammad Saleem, Sobia Yousaf, Malik Saadullah, Memoona Zafar, Rizwan Ullah Khan, Alamgeer Yuchi
Format: Article
Language:English
Published: Universidade de São Paulo 2019-12-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100607&tlng=en
_version_ 1818367725604438016
author Muhammad Asif
Mohammad Saleem
Sobia Yousaf
Malik Saadullah
Memoona Zafar
Rizwan Ullah Khan
Alamgeer Yuchi
author_facet Muhammad Asif
Mohammad Saleem
Sobia Yousaf
Malik Saadullah
Memoona Zafar
Rizwan Ullah Khan
Alamgeer Yuchi
author_sort Muhammad Asif
collection DOAJ
description The current study evaluated antidiabetic and antihyperlipidemic activities of aqueous extract of Sigesbeckia orientalis L. (St. Paul’s Wort) (AESO) in an alloxan-induced diabetic rat model. Following OECD guidelines safe doses of AESO were assessed in rats for the main study. Serum/bood glucose, α-amylase, and lipids levels and histopathological evaluations were conducted to assess antidiabetic and associated antihyperlipidemic efficacies of AESO. AESO was found to be safe up to the dose of 2000 mg/kg. Significant (p < 0.05) reduction in glucose and lipids (total cholesterol, triglycerides, low-density lipoproteins) levels was observed in AESO treatment groups. Serum α-amylase, high-density lipoproteins, and total body weight was increased significantly (p < 0.05) in diabetic rats treated with AESO. Histopathological data showed improvement in hepatocyte and pancreatic β-cells islets architecture. HPLC analysis identified quercetin, gallic acid, vanillic acid, p-coumaric acid, m-coumaric acid and cinnamic acid in AESO which are suggested to be responsible for observed antihyperglycemic and antihyperlipidemic attributes. Further studies to standardise the extract and evaluation of safety profile in long-term toxicity studies are recommended for safe and effective antidiabetic nutraceuticals development.
first_indexed 2024-12-13T22:56:37Z
format Article
id doaj.art-3071dc6e00c14b738ea71844396c87d4
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-12-13T22:56:37Z
publishDate 2019-12-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-3071dc6e00c14b738ea71844396c87d42022-12-21T23:28:29ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902019-12-015510.1590/s2175-97902019000218408Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes modelMuhammad Asifhttps://orcid.org/0000-0002-7681-2684Mohammad SaleemSobia YousafMalik SaadullahMemoona ZafarRizwan Ullah KhanAlamgeer YuchiThe current study evaluated antidiabetic and antihyperlipidemic activities of aqueous extract of Sigesbeckia orientalis L. (St. Paul’s Wort) (AESO) in an alloxan-induced diabetic rat model. Following OECD guidelines safe doses of AESO were assessed in rats for the main study. Serum/bood glucose, α-amylase, and lipids levels and histopathological evaluations were conducted to assess antidiabetic and associated antihyperlipidemic efficacies of AESO. AESO was found to be safe up to the dose of 2000 mg/kg. Significant (p < 0.05) reduction in glucose and lipids (total cholesterol, triglycerides, low-density lipoproteins) levels was observed in AESO treatment groups. Serum α-amylase, high-density lipoproteins, and total body weight was increased significantly (p < 0.05) in diabetic rats treated with AESO. Histopathological data showed improvement in hepatocyte and pancreatic β-cells islets architecture. HPLC analysis identified quercetin, gallic acid, vanillic acid, p-coumaric acid, m-coumaric acid and cinnamic acid in AESO which are suggested to be responsible for observed antihyperglycemic and antihyperlipidemic attributes. Further studies to standardise the extract and evaluation of safety profile in long-term toxicity studies are recommended for safe and effective antidiabetic nutraceuticals development.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100607&tlng=enAntidiabeticSigesbeckia orientalis LAlloxanAntihyperlipidemicHPLC
spellingShingle Muhammad Asif
Mohammad Saleem
Sobia Yousaf
Malik Saadullah
Memoona Zafar
Rizwan Ullah Khan
Alamgeer Yuchi
Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model
Brazilian Journal of Pharmaceutical Sciences
Antidiabetic
Sigesbeckia orientalis L
Alloxan
Antihyperlipidemic
HPLC
title Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model
title_full Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model
title_fullStr Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model
title_full_unstemmed Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model
title_short Antidiabetic activity of aqueous extract of Sigesbeckia orientalis (St. Paul’s Wort) in alloxan-induced diabetes model
title_sort antidiabetic activity of aqueous extract of sigesbeckia orientalis st paul s wort in alloxan induced diabetes model
topic Antidiabetic
Sigesbeckia orientalis L
Alloxan
Antihyperlipidemic
HPLC
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100607&tlng=en
work_keys_str_mv AT muhammadasif antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel
AT mohammadsaleem antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel
AT sobiayousaf antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel
AT maliksaadullah antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel
AT memoonazafar antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel
AT rizwanullahkhan antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel
AT alamgeeryuchi antidiabeticactivityofaqueousextractofsigesbeckiaorientalisstpaulswortinalloxaninduceddiabetesmodel